Literature DB >> 32730916

Volume of hippocampal subregions and clinical improvement following electroconvulsive therapy in patients with depression.

Krzysztof Gbyl1, Egill Rostrup2, Jayachandra Mitta Raghava3, Carsten Andersen4, Raben Rosenberg4, Henrik Bo Wiberg Larsson5, Poul Videbech6.   

Abstract

It is thought that the hippocampal neurogenesis is an important mediator of the antidepressant effect of electroconvulsive therapy (ECT). However, most previous studies failed to demonstrate the relationship between the increase in the hippocampal volume and the antidepressant effect. We reinvestigated this relationship by looking at distinct hippocampal subregions and applying repeated measures correlation. Using a 3 Tesla MRI-scanner, we scanned 22 severely depressed in-patients at three time points: before the ECT series, after the series, and at six-month follow-up. The depression severity was assessed by the 17-item Hamilton Rating Scale for Depression (HAMD-17). The hippocampus was segmented into subregions using Freesurfer software. The dentate gyrus (DG) was the primary region of interest (ROI), due to the role of this region in neurogenesis. The other major hippocampal subregions were the secondary ROIs (n = 20). The general linear mixed model and the repeated measures correlation were used for statistical analyses. Immediately after the ECT series, a significant volume increase was present in the right DG (Cohen's d = 1.7) and the left DG (Cohen's d = 1.5), as well as 15 out of 20 secondary ROIs. The clinical improvement, i.e., the decrease in HAMD-17 score, was correlated to the increase in the right DG volume (rrm = -0.77, df = 20, p < .001), and the left DG volume (rrm = -0.75, df = 20, p < .001). Similar correlations were observed in 14 out of 20 secondary ROIs. Thus, ECT induces an increase not only in the volume of the DG, but also in the volume of other major hippocampal subregions. The volumetric increases may reflect a neurobiological process that may be related to the ECT's antidepressant effect. Further investigation of the relationship between hippocampal subregions and the antidepressant effect is warranted. A statistical approach taking the repeated measurements into account should be preferred in the analyses.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dentate gyrus; Electroconvulsive therapy; Hippocampal subfields; Magnetic resonance imaging; Major depressive disorder

Year:  2020        PMID: 32730916     DOI: 10.1016/j.pnpbp.2020.110048

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  4 in total

1.  Greater Emotional Distress Due to Social Distancing and Greater Symptom Severity during the COVID-19 Pandemic in Individuals with Bipolar Disorder: A Multicenter Study in Austria, Germany, and Denmark.

Authors:  Elena M D Schönthaler; Nina Dalkner; Michaela Ratzenhofer; Eva Fleischmann; Frederike T Fellendorf; Susanne A Bengesser; Armin Birner; Alexander Maget; Melanie Lenger; Martina Platzer; Robert Queissner; Adelina Tmava-Berisha; Christina Berndt; Julia Martini; Michael Bauer; Jon Dyg Sperling; Maj Vinberg; Eva Z Reininghaus
Journal:  Int J Environ Res Public Health       Date:  2022-06-22       Impact factor: 4.614

Review 2.  Parsing the Network Mechanisms of Electroconvulsive Therapy.

Authors:  Amber M Leaver; Randall Espinoza; Benjamin Wade; Katherine L Narr
Journal:  Biol Psychiatry       Date:  2021-11-26       Impact factor: 12.810

3.  Electroconvulsive Therapy-Induced Changes in Functional Brain Network of Major Depressive Disorder Patients: A Longitudinal Resting-State Electroencephalography Study.

Authors:  Shuting Sun; Peng Yang; Huayu Chen; Xuexiao Shao; Shanling Ji; Xiaowei Li; Gongying Li; Bin Hu
Journal:  Front Hum Neurosci       Date:  2022-05-18       Impact factor: 3.473

Review 4.  The Neurobiological Effects of Electroconvulsive Therapy Studied Through Magnetic Resonance: What Have We Learned, and Where Do We Go?

Authors:  Olga Therese Ousdal; Giulio E Brancati; Ute Kessler; Vera Erchinger; Anders M Dale; Christopher Abbott; Leif Oltedal
Journal:  Biol Psychiatry       Date:  2021-05-31       Impact factor: 13.382

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.